UNSPSC 51144127: Lisdexamfetamine dimesylate

This classification denotes a cns stimulant and anorexiant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SJT761GEGS. European Medicines Agency schedules Lisdexamfetamine dimesylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32146. Lisdexamfetamine dimesylate generally arises in the molecular formula C15H25N3O.2CH4O3S. The term 'lisdexamfetamine dimesylate' is a U.S. FDA Orange Book designation. Most nations, for tariff and trade purposes, schedule lisdexamfetamine dimesylate under HS 29242990.

As of Q4 2014, LISDEXAMFETAMINE DIMESYLATE remains US FDA's Preferred Term for this commodity. Lisdexamfetamine dimesylate bears US NLM identifiers UMLS ID C1739826 and NCI Concept Code C76628. SMILES: C[C@@H](CC1CCCCC1)NC(=O)[C@H](CCCCN)N.CS(=O)(=O)O.CS(=O)(=O)O.

UNSPSC 51144127 Lisdexamfetamine dimesylate is a Commodity code that covers pharmaceutical products used in the treatment of attention deficit hyperactivity disorder and related conditions. State and local governments procure this medication primarily through their public health departments, community health centers, and behavioral health agencies to support treatment programs and community health initiatives. The purchasing bodies include county health departments, municipal health offices, and special-purpose public health districts that serve populations requiring ADHD and stimulant-use-disorder treatment as part of broader substance-use and mental-health service delivery.

Recent activity under this code is sparse. A single posted opportunity from Seminole County, Florida (IFB 60459723LAS, posted June 30, 2026, with response due July 26, 2023) solicited Naloxone and drug deactivation systems rather than lisdexamfetamine dimesylate itself, indicating a code-to-opportunity mismatch that limits the relevance of this record to the code's actual pharmaceutical scope. The county procurement was structured as a competitive IFB with quarterly deliveries to the Seminole County Community Health Building, requiring vendor compliance with drug-free workplace certification, E-Verify, and federal audit provisions tied to potential FEMA funding. No other state or local lisdexamfetamine dimesylate solicitations appear in the recent-opportunities record.